Mitochondria in skin: the antioxidants that aim at the organelle

Mitochondria in a skin cell are organelles with an address, and the address is the inner membrane. There the respiratory chain passes electrons through complexes I to IV onto oxygen and, along the way, makes ATP. Some of those electrons leak. Reactive oxygen species form, especially at complex I and complex III. Young keratinocytes and fibroblasts quench a large share of that leak. UV load, inflammation and age worsen the balance. The ads say the cell has run out of battery. The cell is running dirtier.

Classic vitamin C, ascorbic acid, is a serious water-soluble reductant in the cytosol. It rarely reaches the inner mitochondrial membrane in amounts that change electron transport there. A serum in formulation buying at the Kosmetikfachhandel in Munich that promises mitochondrial repair and lists only ascorbic acid is selling the product in the ingredient list, which is a different product from the headline. Fourth-generation antioxidants aim at the organelle itself. Whether a cosmetic emulsion gets them there is a formulation question. Belief is the cheaper raw material, and it fails the assay.

CoQ10 already lives in the chain

Coenzyme Q10, ubiquinone, is native equipment. It carries electrons between complex I or II and complex III and sits in the inner membrane while it does so. The reduced form, ubiquinol, also quenches lipid radicals in that same membrane. Skin contains Q10. Epidermal levels fall with age and after UV, a finding repeated by several groups on human skin. Topical Q10 is biologically plausible, and only if it reaches the membrane. Shine in the oil phase of a cream is a finish. It is a poor electron carrier.

Size and extreme lipophilicity are the cabin problem. Q10 refuses water. It needs an oil, a solvent or a carrier, and even then a large share stays in the stratum corneum. A declared 0.3 percent means little until you know the form, ubiquinone or ubiquinol, and the carrier. Ubiquinol oxidises readily. A yellow open jar on a booth is often already partly oxidised, which you can sometimes smell before you read the certificate. For clinics that means light-shielded, low-air packaging and a certificate that names the form in words a substitute can file.

MitoQ is a different object. It is a ubiquinone tethered to a triphenylphosphonium group. That positive charge pulls the molecule along the mitochondrial membrane potential into the matrix. In pharmacology this is a targeting tool with a long paper trail. In cosmetics, MitoQ and related analogues show up as raw materials, usually at very low levels, because the scaffold is expensive and the safety discussion is unfinished. An analogue shares a family resemblance. Ask for the exact substance. The family name is how stands stay vague at a high price.

PQQ and the slow claim of biogenesis

Pyrroloquinoline quinone, PQQ, is discussed as a cofactor and a signal that can push mitochondrial biogenesis through PGC-1alpha. The data that hold up come mostly from cell culture and from oral work. Controlled treatment-room studies on facial skin are the thin file. Biogenesis means the cell builds more mitochondria or replaces damaged ones. That is slow biology. It will not appear as a same-evening glow after a 50-minute facial, and it will not appear in a photograph taken under warmer light.

PQQ on a label points at a biogenesis hypothesis. A client’s dermis has not been shown, in the chair, to have grown new mitochondria.

For formulation, PQQ is water soluble and redox active. It can react with other redox pairs, including ascorbic acid and Q10, and it is fussy about the wrong partners in the same phase. A combination of vitamin C, Q10 and PQQ sold as a mitochondrial complex has to show that the three do not consume each other in the pack. That is an assay after storage. A triad printed on the carton is graphic design.

In the room, PQQ belongs in a leave-on with a stated concentration. An ampoule whose contents meet air and a metal spatula after opening is a different experiment, run by accident. The laminar hood that accompanies this piece is the right association: redox-active material is made up under controlled conditions. The cabin is where a finished, tested lot meets intact skin. It is a poor compounding bench, and it should stay that way.

• CoQ10 is part of the respiratory chain. Topically it matters when ubiquinone or ubiquinol reaches the membrane.
• Vitamin C stays largely cytosolic. A mitochondria-targeted structure is a different chemical object.
• MitoQ carries a triphenylphosphonium group and follows membrane potential. Analogues have to be named chemically, lot by lot.
• PQQ is linked to PGC-1alpha and mitochondrial biogenesis. The evidence is preclinical. A cabin score would be a new study.
• Redox partners in one formula can consume each other. Shelf stability is part of the effect you think you bought.

Three product layers on one aisle

formulation buying is mixing three product layers in the same lighting. Classic antioxidants, ascorbic acid, vitamin E, ferulic acid, quench radicals in cytosol and membranes and are allowed to do that in plain language. Q10 carriers have one serious claim: topping up an endogenous electron carrier. Targeted molecules such as MitoQ analogues and PQQ justify their price only if identity, concentration and a minimum of penetration or cell data exist.

A buying conversation gets short when the questions are right. Which chemical form? What concentration in the finished formula, measured there, rather than in the raw material? Which skin model, and was the mitochondrion actually addressed, membrane potential, ATP or mitochondrial ROS, or was it a generic radical-scavenging test in a tube? An ORAC number is a tube result. Anyone selling an ORAC number as mitochondrial repair has changed the subject, or is betting you will nod.

Device pairings need the same dryness. Needling raises the chance that a lipophilic molecule goes deeper, and it raises the chance that a non-sterile or oxidised lot meets broken tissue. Q10 oils from open cosmetic jars stay off bleeding skin. If a device is in the protocol, so is the presentation the maker released for it, ideally low-bioburden or sterile. That is hygiene. Longevity vocabulary does not launder it.

A menu sentence you can repeat

An honest treatment description says: care with a Q10 carrier to support the look of skin after UV load, optionally a PQQ leave-on whose concentration is on the data sheet. Repair of mitochondria, a reset of cellular energy, a cancellation of organelle ageing: those sentences ask for a structural finding. A cream does not deliver it. A clinic cannot measure it between a cleanse and a photograph.

The frame stays narrow, which is how it stays usable. Photoprotection is the step that cuts UV-driven mitochondrial ROS hardest, before any serum is worth debating. The carrier in the evening on quiet skin. No metal spatulas in redox-active ampoules. No palm-mixing with acids if the maker keeps the phases apart. You will see dozens of fourth generations In trade buying. Keep the ones whose analytics mention the organelle at all. The rest already have a name chemistry gave them: antioxidant. File them there. The drawer is accurate, and the client can live with accuracy.